|
Recent Newsletters
AI studies show value in cardiac CTA | Trifecta heart valve pulled off market | FDA clears AI to guide echo |
Breaking news: Abbott pulls Trifecta heart valves off the market due to early deterioration |
Risk of errors during defibrillation leads to a new recall | How depression & cognitive dysfunction impact TAVR |
Major recalls | Permanent pacemakers after TAVR | Sustainable cath labs | The rise of AI | More from the last week |
Heart Rhythm Highlights: FDA approves dual-chamber leadless pacemaker | 2 key recalls | AFib after TAVR |
News Alert: GE Healthcare recalls certain SpO2 sensors due to risk of errors during defibrillation |
Economics Highlights: An updated look at salaries in cardiology | CMS proposes more Medicare payment cuts |